OKAN KARATAS

Dr. OKAN KARATAS

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Current Thoracic Surgery
Verified
Journal Article
Open access
OKOKAN KARATAS
OKAN KARATAS
HIHakan Işık
Hakan Işık
KKKuthan Kavaklı
Kuthan Kavaklı
ESErsin Sapmaz
Ersin Sapmaz
HÇHasan Çaylak
Hasan Çaylak
AGAlper Gözübüyük
Alper Gözübüyük

1 October 2013 in European Urology Supplements
Verified
Journal Article
Closed access
MYM.E. Yildirim
M.E. Yildirim
HBH. Badem
H. Badem
MCM. Cavis
M. Cavis
OKOKAN KARATAS
OKAN KARATAS
ECE. Cimentepe
E. Cimentepe

16 September 2026 in Acta Medica Young Doctors
Verified
Journal Article
Open access
PDF file
OKOKAN KARATAS
OKAN KARATAS
Aim: Large language models (LLMs) are increasingly accessible to patients seeking health-related information, including practical advice after treatment for spontaneous pneumothorax. The clinical usefulness of such responses depends not only on overall guideline concordance but also on the avoidance of potentially unsafe recommendations. In the present study, the evaluated advice reflected the models assigned by default through each provider’s free consumer interface rather than investigator-selected model configurations. Methodology: Thirty standardized synthetic scenarios representing routine discharge, lifestyle and travel, recurrence and high-risk situations, secondary spontaneous pneumothorax, and post-discharge emergencies were evaluated using three freely accessible consumer-facing LLMs: ChatGPT (GPT-5.6 Luna), Claude (Sonnet 5 Medium), and Gemini (Flash Lite 3.5). All 90 queries were submitted on a single day (30 August 2026) from Antalya, Türkiye. Responses were assessed against a prespecified scenario-specific reference framework based on contemporary international pneumothorax guidelines. Applicable counselling domains were scored from 0 to 2, and a Guideline Concordance Score (GCS) was calculated for each response. Factual errors, unsupported claims, and clinically significant errors (CSEs) were assessed separately. Results: Ninety responses were evaluated. Mean GCS was 89.0% for Claude, 88.5% for ChatGPT, and 72.7% for Gemini. Overall differences among the models were significant (Friedman statistic=31.19, P<0.001). ChatGPT and Claude did not differ significantly (Holm-adjusted P=0.736), whereas both achieved significantly higher GCS values than Gemini (both P<0.001). All three models achieved a mean and median GCS of 100% in emergency safety scenarios. Factual errors occurred in 0, 7, and 4 responses and unsupported claims in 1, 19, and 10 responses for ChatGPT, Claude, and Gemini, respectively. One CSE was identified, occurring in a Gemini air-travel response. Conclusion: Post-discharge advice obtained from freely accessible consumer chatbot interfaces was heterogeneous in its concordance with the prespecified pneumothorax guideline framework. All interfaces reliably identified overt emergencies, but they differed substantially in factual accuracy, unsupported recommendations, and safety-sensitive counselling such as air travel. Because these differences arose between interfaces that appear equivalent to the user and depend on provider-assigned default configurations rather than matched model selection, the quality of advice may vary at the point of use. Clinicians should anticipate that patients may act on such advice, and should address safety-critical items explicitly at discharge rather than assume they will be covered.

1 January 2026 in Sao Paulo Medical Journal
Verified
Journal Article
Open access
OKOKAN KARATAS
OKAN KARATAS
MAMerve sarı akyüz
Merve sarı akyüz
BACKGROUND: Integrating neoadjuvant therapy into the management of resectable non-small cell lung cancer has fundamentally altered operative decision-making worldwide, yet the evolution of surgical techniques (minimally invasive vs. open, anatomic vs. parenchyma-sparing) has not been fully mapped across global thoracic surgery centers. Although systemic therapy is used to downstage tumors and eradicate micrometastases, treatment-induced fibrosis and changes to the vascular architecture create intraoperative challenges that demand technical adaptation. OBJECTIVES: In this study, we quantified 25 years of published articles on surgical responses to neoadjuvant therapy to identify geographic patterns of innovation and critical gaps in the reporting of functional outcomes. METHODS: We performed comprehensive bibliometric mapping of 1,152 surgical oncology manuscripts (970 original investigations; 182 reviews) indexed in the Web of Science Core Collection from 2000 through 2024, analyzing institutional productivity patterns, international collaboration networks, and temporal shifts in research keywords related to the selection of operative techniques. RESULTS: The volume of publications expanded at an annual rate of 11.69%. Chinese institutions generated 330 manuscripts—28.7% of the total number—emphasizing the development of minimally invasive techniques in the post–neoadjuvant therapy setting. Centers in the United States contributed 222 publications (19.3%), averaging 50.9 citations each. The United States centers were led by the University of Texas MD Anderson Cancer Center (44 publications; 3,220 citations) and Memorial Sloan Kettering Cancer Center (30 publications; 3,357 citations), both of which pioneered parenchyma-preserving approaches. The immunotherapy era, from 2018 onward, showed a three-fold increase in the use of the keywords for “surgical complexity” and “postoperative complications,” reflecting growing academic attention to technical challenges. Core thoracic journals included the Annals of Thoracic Surgery (28 articles) and Journal of Thoracic Oncology (32 articles). CONCLUSION: Our analyses exposed critical imbalances between research focus areas and clinical priorities. Patient selection algorithms and respiratory function outcomes received disproportionately little attention, despite being fundamental to surgical decision-making. Only 12% of studies incorporated pulmonary function assessment, highlighting a research gap that requires immediate prioritization in the era of neoadjuvant therapy.

1 June 2021 in Gulhane Medical Journal
Verified
Journal Article
Closed access
HIHakan Işık
Hakan Işık
MIMerve Şengül İnan
Merve Şengül İnan
OKOKAN KARATAS
OKAN KARATAS
ESErsin Sapmaz
Ersin Sapmaz
HÇHasan Çaylak
Hasan Çaylak
AGAlper Gözübüyük
Alper Gözübüyük

1 September 2017 in European Urology Supplements
Verified
Journal Article
Closed access
OKOKAN KARATAS
OKAN KARATAS
AAA.F. Atmaca
A.F. Atmaca
MAMUSTAFA ALDEMİR
MUSTAFA ALDEMİR
UMU. Micoogullari
U. Micoogullari
AAA. Ardicoglu
A. Ardicoglu